Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Neuropsychopharmacology
  • View all journals
  • Search
  • Log in
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. neuropsychopharmacology
  3. editorials
  4. article
On the Value of Measuring Dopamine, Norepinephrine and Their Metabolites in Schizophrenia
Download PDF
Download PDF
  • Editorial
  • Published: 01 February 1993

On the Value of Measuring Dopamine, Norepinephrine and Their Metabolites in Schizophrenia

  • RenĂ© S. Kahn M.D.1 &
  • Michael Davidson M.D.1 

Neuropsychopharmacology volume 8, pages 93–95 (1993)Cite this article

  • 1253 Accesses

  • 4 Citations

  • Metrics details

Article PDF

Author information

Authors and Affiliations

  1. From the Bronx Veterans Affairs Medical Center, and Mount Sinai Medical School, New York, New York

    René S. Kahn M.D. & Michael Davidson M.D.

Authors
  1. René S. Kahn M.D.
    View author publications

    Search author on:PubMed Google Scholar

  2. Michael Davidson M.D.
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kahn, R., Davidson, M. On the Value of Measuring Dopamine, Norepinephrine and Their Metabolites in Schizophrenia. Neuropsychopharmacol 8, 93–95 (1993). https://doi.org/10.1038/npp.1993.68

Download citation

  • Received: 18 September 1992

  • Accepted: 21 September 1992

  • Issue date: 01 February 1993

  • DOI: https://doi.org/10.1038/npp.1993.68

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

This article is cited by

  • Blood biogenic amines during clozapine treatment of early-onset schizophrenia

    • E. Schulz
    • C. Fleischhaker
    • H. Remschmidt

    Journal of Neural Transmission (1997)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Podcasts
  • Current issue
  • Collections
  • Follow us on Facebook
  • Follow us on Twitter
  • Sign up for alerts
  • RSS feed

About the journal

  • Journal Information
  • Open Access Fees and Funding
  • About the Editors
  • Contact
  • Press Releases
  • About the Partner
  • For Advertisers
  • Subscribe
  • Announcements
  • NPP has a new YouTube channel!
  • Latest Press Release

Publish with us

  • For Authors & Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Neuropsychopharmacology (Neuropsychopharmacol.)

ISSN 1740-634X (online)

ISSN 0893-133X (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited